These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 8962318
1. Clinical safety and tolerability of microemulsion cyclosporine in stable renal transplant patients. Gracida C, Melchor JL. Transplant Proc; 1996 Dec; 28(6):3379. PubMed ID: 8962318 [No Abstract] [Full Text] [Related]
2. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients. Gracida C, Melchor JL, Miranda ME, Bartolano C. Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191 [No Abstract] [Full Text] [Related]
3. Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group. Offermann G, Korn A. Transplant Proc; 1996 Aug; 28(4):2204-6. PubMed ID: 8769201 [No Abstract] [Full Text] [Related]
5. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group. Buchholz B, Korn A. Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195 [No Abstract] [Full Text] [Related]
6. A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group. Massari PU, Grosso S, de Boccardo G, Vásquez MC, Schiavelli RO, Sabbatiello RR, Casadei DH, Rial MC, Jost LJ, Túrin MD, Agost Carreño C A, Maggiora EC, Gadea MM. Transplant Proc; 1996 Dec; 28(6):3365-7. PubMed ID: 8962310 [No Abstract] [Full Text] [Related]
15. Conversion from Sandimmune to Neoral in stable renal transplant recipients. Sandoz Study Group OLN-353. Pescovitz MD. Transplant Proc; 1996 Aug; 28(4):2196-8. PubMed ID: 8769198 [No Abstract] [Full Text] [Related]
16. Use of microemulsion form cyclosporine immediately after kidney transplantation without intravenous cyclosporine. Jirasiritham S, Sumethkul V, Mavichak V, Jirasiritham S. Transplant Proc; 1998 Aug; 30(5):1760-1. PubMed ID: 9723270 [No Abstract] [Full Text] [Related]
17. Conversion of cyclosporine to azathroprine in renal transplant recipients. Bassiri A, Amiranssari B, Gol S. Transplant Proc; 1995 Oct; 27(5):2691. PubMed ID: 7482877 [No Abstract] [Full Text] [Related]
18. Conversion from Sandimmune to Neoral in stable liver graft recipients. Pollard SG, Lodge JP. Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213 [No Abstract] [Full Text] [Related]
19. Case reports on conversion to Neoral therapy in renal transplant patients. Curtis JJ. Transplant Proc; 1996 Aug; 28(4):2221-2; discussion 2218. PubMed ID: 8769205 [No Abstract] [Full Text] [Related]
20. Evaluation of the new cyclosporine formulation, Consupren, in renal transplant patients. Stephan AG, Barbari A, Masri MA, Rizk S, Moubarak R, Frem GJ, Kamel G, Baracat-Khoury W, Karam A. Transplant Proc; 1996 Jun; 28(3):1348-9. PubMed ID: 8658688 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]